Developing new methods for creating drugs using light and special materials
Official title: Bioinspired selective heterogeneous organic photoredox catalysis
Funded at Southern Illinois University Carbondale · NIH-10580485 · Data updated 2026-11-12
This study is exploring a new way to make medicines using special light-driven reactions, which could lead to better and safer drugs for patients who need them.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Illinois University Carbondale NIH-funded |
| Lab location | 1 site (Carbondale, United States) |
| Project start | September 15, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $418,625 |
| NIH project number | 1R15GM148938-01 |
| Project ID | NIH-10580485 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who may benefit from new drug therapies, particularly those with conditions that current medications do not adequately address.
✕Less likely to help
Patients who are not seeking new drug therapies or those with conditions that are already well-managed by existing medications may not benefit from this research.
What this research studies
This research focuses on using innovative light-driven chemical reactions to create new drugs that are difficult to synthesize with traditional methods. By employing unique materials known as porous crystalline molecular frameworks, the project aims to enhance the efficiency and selectivity of these reactions. The approach addresses challenges related to how quickly and effectively the necessary components can interact, which is crucial for producing effective medications. Patients may benefit from the development of new drugs that are more effective and have fewer side effects.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new, more effective drugs for various medical conditions.
How similar studies have gone: While the approach of using light-driven reactions in drug synthesis is gaining interest, this specific methodology involving porous crystalline frameworks is relatively novel and has not been extensively tested.
Where this research is happening
-
Southern Illinois University Carbondale
Carbondale, United States Active
Researchers
- Principal investigator: Deria, Pravas — Southern Illinois University Carbondale
- Study coordinator: Deria, Pravas
Related research
Other NIH-funded projects on the same topics.
-
Rapid pathogen ID and antibiotic testing for bacteremia using immune capture, microfluidics, and AI
A fast, AI-assisted diagnostic system will identify bacteria in blood and determine which antibiotics are likely to work, helping doctors treat bacteremia sooner.
-
Electrografted-MoS2 Immunosensor for Biomarker Detection
A university-led project is developing a robust, covalently linked antibody–MoS2 biosensor to detect biomedical markers.
-
Super-Resolution Confocal Microscope for SIU researchers
A new high-resolution confocal microscope will be purchased for Southern Illinois University, enabling researchers from multiple fields to generate clearer 3D images and advance biomedical work.
-
How social choices shape when to stay with a friend vs. seek food in mice
A study in mice will look at how the brain decides whether to stay with a social partner or pursue food when both options are available.
-
High-speed cell sorting technology for cancer and infectious disease research
A fast, multi-marker cell sorter is being purchased to help SIUC researchers study cancer, immune responses, and infections, plus train students in this cutting-edge technique.
-
How early life stress affects aggression through brain circuitry
This study is looking at how tough experiences in childhood, like feeling alone or going through trauma, can affect the brain and lead to aggressive behavior in adults, with the hope of finding better ways to help people manage their anger.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.